October 5-8, 2020 | 8:00AM EDT | 12:00PM UTC*
*Program is in development and subject to change
Autophagy is an intracellular pathway for degradation that allows for the recycling of cellular components inside lysosomes to sustain tissue homeostasis. Countless effort has been devoted to help unravel the molecular mechanisms that regulate this pathway, but many questions remain unresolved. Therefore, this conference program gathers an interdisciplinary group of scientists to address the current and future challenges in the field such as discussions on the existence of non-canonical forms of the pathway and how selectivity is achieved. This conference also addresses the minimal requirements to generate functional autophagosomes and the molecular bases of autophagy regulation. One of the major themes of this conference is a session which reviews how model systems such as plants, worms and mice help to unravel the physiological roles of this essential pathway and why this research can also be applied to find new therapies for human diseases. For example, while it is now clear that many human pathologies have alterations in autophagy, how scientists could potentially manipulate the pathway in vivo is a major challenge that will be addressed at this conference. Finally, this conference provides a unique frame to display the current research and future challenges of the field during physiological and pathological conditions.
Program is intended for scientific researchers and clinical audiences.
Join us for this landmark virtual event, brought to you by Keystone Symposia.
Registration for this meeting is now closed.
ePoster Abstract Submission: Passed
Financial Aid Application: Passed
Eric H. Baehrecke
University of Massachusetts Medical School, USA
Centro de Investigaciones Biológicas, CSIC, Spain
Ana Maria Cuervo
Albert Einstein College of Medicine, USA
Goethe University Medical School, Germany
Max Planck Institute for Biology of Aging, Germany
Juntendo University School of Medicine, Japan
Cordeliers Research Center, France
NIEHS, National Institutes of Health, USA
University of Utah School of Medicine, USA
Queens College - CUNY, USA
University of Tokyo, Japan
Leon O. Murphy
Casma Therapeutics, USA
University of Tuebingen, Germany
NHLBI, National Institutes of Health, USA
Medical Research Council, UK
University Medical Centre Groningen, Netherlands
David C. Rubinsztein
Cambridge Institute for Medical Research, UK
University of Oxford, UK
University of Oslo, Norway
Herbert (Skip) W. Virgin
Vir Biotechnology, USA
Richard J. Youle
NINDS, National Institutes of Health, USA
Chinese Academy of Sciences, China
Funding for this conference was made possible (in part) by Grant No. 1R13CA254442-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.